[Eicosanoids, vascular function and atherosclerosis].
Icosanoides (prostaglandins, leukotrienes) seem to play an essential part in cardiovascular pathology. A range of experimental data obtained both in vitro and in vivo has resulted in a rapid progression of our understanding of their biochemical and functional properties and has opened up new fields of pharmacological research. However, a clear cut demonstration of their clinical relevance remains difficult. Improved methodology will no doubt provide more information about the importance of these compounds. For the present, we recommend reexamination of previously reported results.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism*; D002478:Cells, Cultured; D004727:Endothelium / Q000166:cytology / Q000378:metabolism; D006801:Humans; D007975:Leukotriene B4 / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D011453:Prostaglandins / Q000502:physiology*; D011817:Rabbits; D013189:SRS-A / Q000502:physiology*; D013928:Thromboxane A2 / Q000502:physiology*
D001095:Arachidonic Acids; D011453:Prostaglandins; D013189:SRS-A; D007975:Leukotriene B4; D013928:Thromboxane A2
Icosanoïdes, fonction vasculaire et athérosclérose.